Canaan Partners X LLC, 10% Owner at Protagonist Therapeutics, Inc (PTGX), sold 119,900 shares at $20.71 ($2.5M) on 2018-03-23, disclosed to the SEC on 2018-03-26.
Open-market sale of $2.5M PTGX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.71 | 59,950 | $1.2M | 50.0% |
| 2 | $20.71 | 59,950 | $1.2M | 50.0% |
| Total | $20.71 avg | 119,900 | $2.5M | 100% |
| Filing → |
| PTGX | SELL | 2018-03-19 | $837K | — | Filing → |
| PTGX | SELL | 2018-03-15 | $514K | — | Filing → |